We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Virus Linked to Development of Common Form of Skin Cancer

By LabMedica International staff writers
Posted on 11 Aug 2009
Cancer researchers have linked a virus implicated in the development of a rare, deadly form of skin cancer to the much more common and treatable type of skin cancer, squamous cell carcinoma (SCC).

Investigators from Ohio State University (Columbus, USA) had speculated that the Merkel cell polyomavirus (MCPyV), which could be isolated from patients with the relatively rare skin cancer Merkel cell carcinoma, might also play a role in the development of the milder and more common SCC. More...
To test this hypothesis the investigators used polymerase chain reaction (PCR) with primer sets directed against the large T (LT) antigen and VP1 gene of MCPyV.

The investigators reported in the June 25, 2009, online edition of the Journal of Investigative Dermatology that they had detected MCPyV in 15% (26/177) of SCC DNA samples and 17% (11/63) of adjacent skin DNA samples from 21 of 58 (36%) individuals studied. They did not detect MCPyV in any matched normal blood DNA (0/57), but observed the presence of MCPyV DNA in one of 12 normal mouthwash DNAs. All sequenced SCC samples had a common mutation that shortened the LT antigen, which provided indirect evidence of viral integration into the cancer cells.

"This is indirect evidence that the virus might play a role in causing some cases of squamous cell carcinoma,” said senior author Dr. Amanda E. Toland, assistant professor of molecular virology, immunology, and medical genetics at Ohio State University. "Originally it was thought that this virus caused only this rare skin cancer, but our findings indicate that it is a lot more prevalent than we initially thought. That suggests that the virus may develop a mutation that causes it to integrate into host-cell DNA, and therefore, may play a role in causing the cancer. If it proves to be a cancer-causing virus, and if it proves to be common in the general population, it might be something we should begin screening people for.”

Related Links:
Ohio State University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Automated Clinical Chemistry Analyzer
Envoy 500+
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings support integrating high-performing plasma p-tau217 assays into Alzheimer’s diagnostic workflows, provided that platform-specific calibration and standardized testing protocols are in place. (Image Credit: Adobe Stock)

Head-to-Head Study Compares Blood Tests for Early Alzheimer’s Disease Detection

Accurate, scalable diagnostics are becoming increasingly important as disease-modifying therapies reshape Alzheimer’s disease care, yet many patients still rely on invasive cerebrospinal fluid sampling... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.